Comparison of Postoperative Outcomes of Laparoscopic Lateral Suspension and V-NOTES Lateral Suspension With the Salman Ketenci Gencer Technique
Launched by GAZIOSMANPASA RESEARCH AND EDUCATION HOSPITAL · Jan 25, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical techniques for treating pelvic organ prolapse, a condition where pelvic organs drop from their normal position. The trial compares a method called laparoscopic lateral suspension with another called V-NOTES lateral suspension, both using a specific technique developed by a doctor named Salman Ketenci Gencer. The goal is to see which method leads to better early recovery outcomes for patients.
To participate in this trial, women aged 27 to 74 years who are sexually active and experiencing stage 3 or 4 pelvic organ prolapse may be eligible. However, individuals with certain conditions, such as cervical problems, past surgeries related to the cervix, significant obesity, or any signs of pregnancy, cannot join. If you choose to participate, you can expect to undergo one of the two surgical techniques and be monitored for your recovery in the weeks following the procedure. This research aims to improve treatment options and outcomes for women dealing with pelvic organ prolapse.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with stage 3 or 4 pelvic organ prolapse Sexually active patients
- Exclusion Criteria:
- • Cervical pathology History of loop electrosurgical excision procedure (LEEP) or conization Presence of vaginal, pelvic, or adnexal mass Suspicious abdominal malignancy Morbid obesity Any pelvic infection Signs of pregnancy
About Gaziosmanpasa Research And Education Hospital
Gaziosmanpasa Research and Education Hospital is a leading healthcare institution dedicated to advancing medical research and education. With a commitment to innovative clinical practices, the hospital serves as a hub for clinical trials aimed at improving patient outcomes and enhancing therapeutic options. The institution fosters collaboration among multidisciplinary teams, integrating cutting-edge research with exceptional patient care. By prioritizing ethical standards and regulatory compliance, Gaziosmanpasa Research and Education Hospital is poised to contribute significantly to the field of medical science and the development of new treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported